These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 6743722
21. Urinary excretion of MHPG and normetanephrine in attention deficit hyperactivity disorder. Baker GB, Bornstein RA, Douglass AB, Van Muyden JC, Ashton S, Bazylewich TL. Mol Chem Neuropathol; 1993; 18(1-2):173-8. PubMed ID: 8466590 [Abstract] [Full Text] [Related]
26. Norepinephrine and dopamine metabolites and educational variables in boys with attention deficit disorder and hyperactivity. Shekim WO, Sinclair E, Glaser R, Horwitz E, Javaid J, Bylund DB. J Child Neurol; 1987 Jan; 2(1):50-6. PubMed ID: 3624828 [Abstract] [Full Text] [Related]
27. Effect of diet on urinary MHPG excretion in depressed patients and normal control subjects. Muscettola G, Wehr T, Goodwin FK. Am J Psychiatry; 1977 Aug; 134(8):914-6. PubMed ID: 879357 [Abstract] [Full Text] [Related]
28. Effects of diet on urinary excretion of MHPG in normal preadolescent boys. Shekim WO, Rutledge MJ, Javaid J, Dekirmenjian H, Davis JM. Am J Psychiatry; 1983 Apr; 140(4):476-9. PubMed ID: 6837789 [Abstract] [Full Text] [Related]
31. [The effects of psychostimulants on the cognitive results and behaviour of children with the combined subtype of attention deficit with hyperactivity]. Mulas F, Roselló B, Morant A, Hernández S, Pitarch I. Rev Neurol; 1981 Oct; 35(1):17-24. PubMed ID: 12389187 [Abstract] [Full Text] [Related]
32. Urinary amine metabolite excretion in a patient with adrenergic hyperactivity state: reaction to phenelzine withdrawal and combined treatment. Modai I, Beigel Y, Cygielman G. J Clin Psychiatry; 1986 Feb; 47(2):92-3. PubMed ID: 2418010 [Abstract] [Full Text] [Related]
33. Free and conjugated 3-methoxy-4-hydroxyphenylglycol in human urine: peripheral origin of glucuronide. Peyrin L, Pequignot JM. Psychopharmacology (Berl); 1983 Feb; 79(1):16-20. PubMed ID: 6403958 [Abstract] [Full Text] [Related]
34. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study. Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK. Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731 [Abstract] [Full Text] [Related]
35. The urinary excretion of 3-methoxy-4-hydroxyphenylglycól in acute myocardial infarction. Wocial B, Sznajderman M, Januszewicz W, Raczyński J. Clin Chim Acta; 1979 Aug 01; 95(3):517-20. PubMed ID: 487590 [Abstract] [Full Text] [Related]
36. Urinary excretion of catecholamine metabolites in hyperkinetic child syndrome. Khan AU, Dekirmenjian H. Am J Psychiatry; 1981 Jan 01; 138(1):108-10. PubMed ID: 7446760 [No Abstract] [Full Text] [Related]
37. Decreased 24-hour urinary MHPG in childhood autism. Young JG, Cohen DJ, Caparulo BK, Brown SL, Maas JW. Am J Psychiatry; 1979 Aug 01; 136(8):1055-7. PubMed ID: 464131 [Abstract] [Full Text] [Related]
38. Phenelzine in depressed patients. Effects on urinary MHPG excretion in relation to clinical response. Beckmann H, Murphy DL. Neuropsychobiology; 1977 Aug 01; 3(1):49-55. PubMed ID: 895998 [Abstract] [Full Text] [Related]
39. [Phonological processing in children with attention deficit hyperactivity disorder: is methylphenidate effective?]. Miranda-Casas A, Ygual-Fernández A, Mulas-Delgado F, Roselló-Miranda B, Bó RM. Rev Neurol; 2002 Feb 01; 34 Suppl 1():S115-21. PubMed ID: 12447801 [Abstract] [Full Text] [Related]
40. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Research Units on Pediatric Psychopharmacology Autism Network. Arch Gen Psychiatry; 2005 Nov 01; 62(11):1266-74. PubMed ID: 16275814 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]